Michel Vignes

3.5k total citations
76 papers, 2.9k citations indexed

About

Michel Vignes is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Michel Vignes has authored 76 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Cellular and Molecular Neuroscience, 35 papers in Molecular Biology and 10 papers in Physiology. Recurrent topics in Michel Vignes's work include Neuroscience and Neuropharmacology Research (40 papers), Ion channel regulation and function (17 papers) and Insect and Pesticide Research (8 papers). Michel Vignes is often cited by papers focused on Neuroscience and Neuropharmacology Research (40 papers), Ion channel regulation and function (17 papers) and Insect and Pesticide Research (8 papers). Michel Vignes collaborates with scholars based in France, United Kingdom and Spain. Michel Vignes's co-authors include Graham L. Collingridge, Janique Guiramand, Fabien Lanté, Catherine Cohen‐Solal, Max Récasens, Kumlesh K. Dev, Janine M. Barnes, Jeremy M. Henley, Ramesh Chittajallu and Tangui Maurice and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Michel Vignes

74 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Vignes France 24 1.7k 1.3k 618 334 321 76 2.9k
Frédéric Knoflach Switzerland 30 2.5k 1.5× 1.9k 1.5× 697 1.1× 584 1.7× 330 1.0× 59 3.9k
Lori L. McMahon United States 34 1.8k 1.1× 1.5k 1.2× 674 1.1× 481 1.4× 311 1.0× 80 3.4k
Thomas H. Lanthorn United States 31 2.0k 1.2× 1.4k 1.1× 596 1.0× 316 0.9× 191 0.6× 67 3.0k
Marc Marien France 32 1.5k 0.9× 803 0.6× 343 0.6× 343 1.0× 386 1.2× 48 2.6k
Eric S. Nisenbaum United States 32 2.4k 1.4× 1.5k 1.2× 564 0.9× 403 1.2× 207 0.6× 75 3.3k
Rami Yaka Israel 26 1.3k 0.8× 1.0k 0.8× 380 0.6× 233 0.7× 210 0.7× 55 2.2k
Zhifang Dong China 28 1.1k 0.6× 829 0.7× 666 1.1× 527 1.6× 468 1.5× 97 2.5k
Shelley J. Russek United States 31 1.9k 1.1× 1.5k 1.2× 324 0.5× 221 0.7× 262 0.8× 58 2.9k
John Q. Wang United States 40 3.2k 1.9× 2.6k 2.1× 577 0.9× 445 1.3× 392 1.2× 137 4.6k
Xavier Langlois Belgium 38 2.3k 1.4× 2.1k 1.7× 397 0.6× 510 1.5× 330 1.0× 104 4.2k

Countries citing papers authored by Michel Vignes

Since Specialization
Citations

This map shows the geographic impact of Michel Vignes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Vignes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Vignes more than expected).

Fields of papers citing papers by Michel Vignes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Vignes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Vignes. The network helps show where Michel Vignes may publish in the future.

Co-authorship network of co-authors of Michel Vignes

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Vignes. A scholar is included among the top collaborators of Michel Vignes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Vignes. Michel Vignes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vignes, Michel, et al.. (2025). Neuroprotection by chronic administration of Fluoroethylnormemantine (FENM) in mouse models of Alzheimer's disease. Alzheimer s Research & Therapy. 17(1). 7–7. 2 indexed citations
2.
Cens, Thierry, Alain Chavanieu, Matthieu Rousset, et al.. (2024). Honeybee CaV4 has distinct permeation, inactivation, and pharmacology from homologous NaV channels. The Journal of General Physiology. 156(5).
3.
Ménard, Claudine, Matthieu Rousset, Julien Roussel, et al.. (2023). Functional Characterization of Four Known Cav2.1 Variants Associated with Neurodevelopmental Disorders. Membranes. 13(1). 96–96. 3 indexed citations
4.
Cens, Thierry, Alain Chavanieu, Julien Roussel, et al.. (2022). Molecular Targets of Neurotoxic Insecticides in Apis mellifera. European Journal of Organic Chemistry. 2022(21). 9 indexed citations
6.
Rousset, Matthieu, Claude Collet, Thierry Cens, et al.. (2017). Honeybee locomotion is impaired by Am-CaV3 low voltage-activated Ca2+ channel antagonist. Scientific Reports. 7(1). 41782–41782. 9 indexed citations
7.
Crouzin, Nadine, Mélanie Cavalier, Janique Guiramand, et al.. (2012). Synthesis and characterization of a cyclooctapeptide analogue of ω-agatoxin IVB enhancing the activity of CaV2.1 calcium channels activity in cultured hippocampal neurons. Neurochemistry International. 61(5). 632–639. 2 indexed citations
8.
Moreno, Estefanía, Hanne M. Hoffmann, Marta González-Sepúlveda, et al.. (2010). Dopamine D1-histamine H3 Receptor Heteromers Provide a Selective Link to MAPK Signaling in GABAergic Neurons of the Direct Striatal Pathway. Journal of Biological Chemistry. 286(7). 5846–5854. 99 indexed citations
9.
Lanté, Fabien, Johann Meunier, Janique Guiramand, et al.. (2008). Late N‐acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation. Hippocampus. 18(6). 602–609. 109 indexed citations
10.
Lanté, Fabien, Mélanie Cavalier, Catherine Cohen‐Solal, Janique Guiramand, & Michel Vignes. (2006). Developmental switch from LTD to LTP in low frequency‐induced plasticity. Hippocampus. 16(11). 981–989. 35 indexed citations
11.
Crouzin, Nadine, Gérard Barbanel, Catherine Cohen‐Solal, et al.. (2005). A transient treatment of hippocampal neurons with α-tocopherol induces a long-lasting protection against oxidative damage via a genomic action. Free Radical Biology and Medicine. 39(8). 1009–1020. 28 indexed citations
14.
Bortolotto, Zuner A., Vernon R. J. Clarke, Michael C. Parry, et al.. (1999). Kainate receptors are involved in synaptic plasticity. Nature. 402(6759). 297–301. 265 indexed citations
15.
Vignes, Michel, Vernon R. J. Clarke, Mair Parry, et al.. (1998). The GluR5 subtype of kainate receptor regulates excitatory synaptic transmission in areas CA1 and CA3 of the rat hippocampus. Neuropharmacology. 37(10-11). 1269–1277. 126 indexed citations
16.
Vignes, Michel & Graham L. Collingridge. (1997). The synaptic activation of kainate receptors. Nature. 388(6638). 179–182. 360 indexed citations
17.
Chittajallu, Ramesh, Michel Vignes, Kumlesh K. Dev, et al.. (1996). Regulation of glutamate release by presynaptic kainate receptors in the hippocampus. Nature. 379(6560). 78–81. 339 indexed citations
18.
Vignes, Michel, Emmanuelle Blanc, & Max Récasens. (1995). Stimulation of Ca2+‐Activated Non‐specific Cationic Channels by Phospholipase C‐linked Glutamate Receptors in Synaptoneurosomes?. European Journal of Neuroscience. 7(8). 1791–1802. 10 indexed citations
19.
Vignes, Michel, et al.. (1995). Excitatory Amino Acid Metabotropic Receptor Subtypes and Calcium Regulation. Annals of the New York Academy of Sciences. 757(1). 418–429. 20 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026